A powerful showing by Australian tech stocks has pulled the ASX out of the red to post a 0.24pc gain despite weakness in Energy and Resource sectors.
Andromeda Metals has pulled off a testwork breakthrough by producing ultra-high purity 4N HPA using its own low-cost process and kaolin.
Although the lithium market is facing challenges, lithium resource stocks are maintaining momentum with active exploration.
Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
Some of the ASX’s most exciting health small caps rolled out their quarterly results this week, including Control Bionics, LTR Pharma, Lumos Diagnostics and EMvision Medical Devices.
Decidr AI Industries and Adisyn are among ASX technology companies reporting March quarterly results this week.
